Emerging Cell-Based Therapies (CAR-T, TILs) and Their Availability in India
Recent years have seen significant changes in the treatment of cancer. In the past, the primary treatments were radiation, chemotherapy, and surgery. Newer therapies are now being used in clinical settings. Cell-based treatment is one significant development.
Among these, TIL treatment and CAR-T therapy are receiving greater interest.These therapies use the patient’s own immune cells to fight cancer. They are giving hope to patients who do not respond well to regular treatment.
India has also entered this field. Indian hospitals and biotechnology companies are now developing advanced cell therapies at a lower cost compared to many western countries.
What is Cell-Based Therapy?
Cell-based therapy means using living cells as treatment. In cancer care, immune cells are collected from the patient.In the lab, these cells are altered or triggered. They are then returned to the patient in order to combat cancer cells.
Chemotherapy is not the same as this method. Chemotherapy targets both cancerous and healthy cells. The primary target of cell treatments is cancer cells. This lessens the harm done to healthy tissue.
CAR-T therapy has shown good results in certain blood cancers such as:
- Acute lymphoblastic leukemia (ALL)
- Non-Hodgkin lymphoma
- Large B-cell lymphoma
In many patients, CAR-T therapy has helped even after chemotherapy or stem cell transplant failed.
India’s Progress in CAR-T Therapy
India made a major breakthrough with NexCAR19. It is India’s first approved CAR-T therapy. The therapy was developed by Immuno ACT in collaboration with Tata Memorial Centre and researchers from Indian Institute of Technology Bombay.
NexCAR19 is mainly used for relapsed or refractory B-cell cancers. These are cancers that return after treatment or do not respond to treatment.
One important benefit is affordability. In countries like the United States, CAR-T therapy may cost several crores of rupees. India’s NexCAR19 therapy is available at a much lower price, making it more accessible for Indian patients.
Several cancer centers in India are now offering CAR-T treatment.Infrastructure for these cutting-edge treatments is rapidly being built in major cities like Chennai, Bengaluru, Delhi, and Mumbai.
What is TIL Therapy?
TIL stands for Tumor Infiltrating Lymphocyte therapy.
There are some minor differences between this treatment and CAR-T therapy. In TIL treatment, immune cells are harvested directly from the tumor tissue. These immune cells are already fighting the cancer of the body.
These cells are gathered by doctors, who then cultivate them in great quantities in the lab. They are subsequently reinfused into the patient.
TIL therapy is mainly being studied for solid tumors such as:
- Melanoma
- Cervical cancer
- Lung cancer
- Head and neck cancers
Researchers believe TIL therapy may become important for cancers where CAR-T therapy is less effective.
Does India Offer TIL Therapy?
TIL treatment is still primarily limited to clinical trials and research studies in Indiabecause it hasn't yet reached the commercial market.
TIL-based methods are being investigated by a few academic hospitals and cancer research facilities. Interest in this therapy is growing because India has a large cancer burden and increasing biotechnology support.
Experts believe more Indian clinical trials may start in the coming years.
Benefits of Cell-Based Therapies
Ø Personalized treatment
The therapy is made from the patient’s own immune cells. So the treatment is personalized.
Ø Hope for resistant cancers
Some patients do not improve with chemotherapy or radiation. CAR-T therapy has shown positive outcomes in such difficult cases.
Ø Better targeting
These therapies mainly target cancer cells. This may reduce harm to healthy tissues.
Ø Long-term response
Some patients remain cancer-free for long periods after treatment. Research is still continuing in this area.
Challenges in India:
Even though progress is happening, there are still challenges.
Ø High cost
Indian therapies are cheaper than western therapies. Still, treatment cost can be high for many families.
Ø Limited centers
Only selected hospitals have facilities for cell therapy. Rural patients may find it difficult to access treatment.
Ø Need for experts
CAR-T therapy needs trained oncologists, laboratory experts, and intensive monitoring teams.
Side effects
Patients may develop complications such as:
- Fever
- Low blood pressure
- Neurological symptoms
- Cytokine release syndrome (CRS)
Because of this, treatment should only be done in specialized centers.
Future of Cell Therapies in India
India is becoming an important player in cancer biotechnology. Government support, academic research, and private companies are helping in the growth of this field.
ü CAR-T treatments for solid tumors
ü CAR-T products that are safer
ü Quicker production techniques
ü More reasonably priced treatments
ü Cell-based treatments might eventually be a standard component of cancer care in India.
FAQs
1. Does CAR-T treatment exist in India?
Indeed.CAR-T therapy is available in selected cancer hospitals in India. NexCAR19 is India’s first approved CAR-T therapy for certain blood cancers.
2. For which cancers can CAR-T therapy be effective?
CAR-T therapy is the main treatment for two blood malignancies: leukemia and lymphoma.
3. Is CAR-T therapy very expensive?
It is expensive. But Indian-developed therapies are much cheaper compared to treatments available in western countries.
4.Does India have access to TIL therapy?
TIL therapy is currently only available in clinical studies in India.
5. What about safety?
Physicians keep a careful eye on their patients during the process. Despite the possibility of adverse effects, professional facilities are ready to handle any problems.
6. Can cancer be totally cured with these treatments?
Some patients show long-term remission. However, results vary from patient to patient.
Conclusion
Cell-based therapies are changing the future of cancer treatment. Blood malignancies have previously responded well to CAR-T treatment. India has made great strides in this area with the development of affordable CAR-T treatment. More hospitals and research centers are expected to use these technologies in the future years.
For patients and caregivers, these therapies bring new hope. At the same time, it is important to discuss treatment options with qualified oncologists before making decisions.
References
